Navigation Links
IRIDEX Reports Record 2012 Fourth Quarter Results
Date:2/28/2013

es Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the size and growth of and trends in the markets in which the Company operates, the success of the Company's development, marketing and sales efforts, MicroPulse laser therapy, the Company's growth strategy, the Company's acquisition strategy, sales revenue growth, operational plans, profitability, the Company's projected fiscal 2013 financial results and the Company's share repurchase program. These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2012, June 30, 2012 and September 29, 2012 which were filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

TABLES FOLLOW

 IRIDEX CorporationCondensed Consolidated Statements of Operations(In thousands, except per share data)(unaudited)Three Months EndedTwelve Months EndedDecember 29,December 31,December 29,December 31,2012201120122011Total revenues

$
9,228$
8,620$
33,859$
33,159Cost of revenues

4,8904,34217,51316,869Gross profit

4,3384,27816,34616,290Operating expenses:Research and development

1,0911,1664,3853,913Sales and marketing

2,0342,1477,8957,458General and administrative

9081,0664,9264,259Legal settlement, net of expenses

-(1,274)-(1,274)Total operating expenses

4,0333,10517,20614,356Income (loss) from operations

3051,173(860)1,934Legal settlement

--800800Other expense, net

(18)(250)(210)(296)Income (loss) from continuing opera
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. IRIDEX Announces Fourth Quarter and Full Year 2012
2. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
3. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
4. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
5. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
6. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
7. IRIDEX Reports 2012 Third Quarter Results
8. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
9. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
10. IRIDEX Reports 2012 Second Quarter Results
11. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , 14 de julio de 2014 /PRNewswire-HISPANIC PR ... anunciar que Barry Epling , presidente de la ... CEO de la Compañía. El señor Epling es el ... que otorgó la licencia de su formulación, sus propiedades ... proveedor de apoyo financiero. "El señor ...
(Date:7/14/2014)... , July 14, 2014  Invivotek L.L.C., a ... pleased to announce that its animal research facility ... the Assessment and Accreditation of Laboratory Animal Care ... animals in science worldwide through voluntary accreditation and ... animal care and use in 38 countries. ...
(Date:7/14/2014)... July 14, 2014 Valeant Pharmaceuticals International, ... VRX) today announced it has filed a premerger ... 1976 (HSR) with the U.S. Federal Trade Commission ... Inc. (NYSE: AGN). About Valeant ... International, Inc. (NYSE/TSX: VRX) is a multinational specialty ...
Breaking Medicine Technology:BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5
... PCI program is critical, CHICAGO, March 29 ... and successfully in medical centers without,on-site cardiac surgical ... to quality. These are the findings of the,largest ... have on-site,cardiac surgery to PCI programs that transfer ...
... days and out to 450 days in patients who ... either bare metal or drug-eluting stents, CHICAGO, March 29 ... and highly,statistically significant reduction in the risk of coronary stent,thrombosis ... fatal consequences - in patients who received a stent as,compared ...
Cached Medicine Technology:Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 2Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 3Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 2Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 3Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 5Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 6Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 7
(Date:7/14/2014)... According to a new market research report ... and Others), Devices (Power IC, Power Module & Power ... 2014 - 2020", the Power Electronics market is expected ... market is valued at $36.86 Billion and expected to ... The report also includes an in-depth analysis of the ...
(Date:7/14/2014)... SingaporeA*STAR,s Bioprocessing Technology Institute (BTI) has entered into ... pharmaceutical company, Roche, to identify novel drug candidates ... partnership brings together BTI,s capabilities in novel antibody ... (mAbs) therapeutics, opening up the possibility of ... death worldwide. , The collaboration makes use ...
(Date:7/14/2014)... Botanica Day Spa announced last month that ... at the day spa in down town Clearwater, FL ... other refreshments will be served as clients are invited ... products and great deals on spa services, including ... Dermaplaning (also known as “facial shaving”) is a simple ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, July ... a faltering sense of smell might signal the early ... smell test could spot who needs more extensive screening ... ability to identify odors was associated with the loss ... "We,re trying to be able to diagnose Alzheimer,s ...
(Date:7/14/2014)... Amy Norton HealthDay ... Older adults who enjoy mentally stimulating games may have bigger ... suggests. The study looked at the connection between playing ... acuity for adults in their 50s and 60s. Researchers ... other day performed better on tests of memory and other ...
Breaking Medicine News(10 mins):Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 2Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 3Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 5Health News:A*STAR partners Roche to develop new cancer therapeutics 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Can Games, Puzzles Keep Aging Minds Sharp? 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 3
... a newborn baby going under the knife to repair a ... work begins for parents. University of Alberta nursing professor Gwen ... a former pediatric cardiology nurse; she wanted to find out ... per cent convinced that health-care professionals get what these parents ...
... 26 The Providence Service,Corporation (Nasdaq: PRSC ) ... financial advisor. , In ... strategic,options relating to, among other things, delevering its debt, growing ... UBS,Investment Bank has been retained in connection with selling certain,non-strategic ...
... Stylists, beauticians may be affected by phthalates in these ... -- Mothers exposed to a common hairspray chemical while ... born with an abnormally placed urinary opening, a new ... fragrances, and nail and hair products contain chemicals called ...
... are misaligned and point outward are at significantly ... adulthood, according to findings of a Mayo Clinic ... ( http://pediatrics.aappublications.org/cgi/content/full/122/5/1033 ), the official journal of the ... examined the medical records of 407 patients with ...
... it,s cheaper and less time-consuming than in-person visits, study ... counseling may be as effective as face-to-face counseling in ... University of Florida study included 234 obese women, ages ... Florida. , All the women completed a six-month weight-loss ...
... Public engagement practitioners from across the world are to ... be held in South Africa, organised by the Wellcome ... engage to empower" will take place from 2-5 ... Studies, KwaZulu-Natal. It will bring together practitioners working in ...
Cached Medicine News:Health News:Parents are the unsung heroes 2Health News:Providence Service Corporation Retains UBS Investment Bank as its Financial Advisor in Connection With the Sale of Certain Non-Strategic Assets 2Health News:Over-the-Phone Weight Loss Counseling Works 2Health News:International workshop aims to boost public engagement work in developing countries 2Health News:International workshop aims to boost public engagement work in developing countries 3
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: